Saragossa, Spain

Pedro Moreo Calvo

This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Ebers Medical Technology, S.l. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedro Moreo Calvo. Retrieved from https://idiyas.com/inventor/pedro-moreo-calvo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pedro Moreo Calvo - Innovator in Medical Technology

Introduction: Pedro Moreo Calvo is an inventor based in Zaragoza, Spain. He is currently associated with Ebers Medical Technology, S.L. Although he has not yet been granted any patents, his work focuses on developing innovative medical devices.

Latest Patent Applications: One of his notable patent applications is for a "Normothermic Perfusion Device Suitable for Maintaining a Liver or a Kidney in Optimal Physiological Conditions." This invention relates to a device designed to maintain optimal physiological conditions for both a liver and a kidney intended for transplantation. The device comprises a permanent part and a disposable part. The disposable part includes a container adapted to house a liver or kidney and a hydraulic circuit that channels perfusion fluid and vasodilator fluid to the organ. The permanent part features a relief configured to house at least two containers of different dimensions and geometric configurations.

Conclusion: Pedro Moreo Calvo is making strides in the field of medical technology with his innovative ideas and applications. His work has the potential to significantly impact organ transplantation procedures.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…